Defined Xenofree Reprogramming of Cord Blood Progenitors to Induced Pluripotent and Blastomere-Like Stem Cells
Journal of Visualized Experiments · 2025
DOI: 10.3791/68613 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2025. Verfasst von Tea Soon Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Division of Pediatric Oncology and Institute for Cell Engineering, The Johns Hopkins University School of Medicine. Hauptthemen laut MEDLINE: Fetal Blood, Induced Pluripotent Stem Cells, Blastomeres, Cellular Reprogramming. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NEI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Human cord blood (CB) myeloid progenitor reprogramming to a high-fidelity human induced pluripotent stem cell (hiPSC) state can be achieved using non-integrating episomal vectors and stromal signals. These conventional, primed CB-hiPSC lines can subsequently be chemically reverted with high efficiencies to a blastomere-like Tankyrase/PARP Inhibitor-Regulated Naive Stem Cell (TIRN-SC) state with functional totipotency. PARP-regulated TIRN-SCs are human stem cells with high epigenetic plasticity, stable epigenomic imprints, and have greater differentiation potency than conventional, lineage-primed hiPSCs. Here, optimized XF/FF methods are outlined for efficient mesenchymal stroma-activated episomal reprogramming of CD34+ CD33+ CB myeloid progenitors into conventional XF/FF hiPSC. TIRN reversion reproducibly potentiated XF/FF conventional hiPSC to adopt transcriptional, epigenetic, and functional features of cleavage-stage human embryo cells with decreased lineage-primed gene expression. We validated that TIRN-reverted CB-derived XF-hiPSC displayed marked improvement in directed multi-lineage differentiation (including hematovascular lineages) across a broad repertoire of genetically independent backgrounds. These methods serve as a first step for generating cGMP-compliant TIRN-SC lines for clinical-grade HLA-defined 'Universal' donor TIRN-SC (UTIRN-SC) banks. The derivation of UTIRN-SC lines with improved differentiation versatility from CD34+ CD33+ CB progenitors could have a high impact on regenerative medicine. For example, UTIRN-SCs could generate tissue banks of HLA-defined, cryo-preserved cardiac, vascular, and neural donor progenitors for comprehensive multi-lineage "off-the-shelf" cellular therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Oncology, Division of Pediatric Oncology and Institute for Cell Engineering, The Johns Hopkins University School of Medicine.
- Department of Oncology, Division of Pediatric Oncology and Institute for Cell Engineering, The Johns Hopkins University School of Medicine; lzimme14@jhmi.edu.
- Department of Oncology, Division of Pediatric Oncology and Institute for Cell Engineering, The Johns Hopkins University School of Medicine; Ezambid1@jhmi.edu.
Förderung
- NICHD NIH HHS
- NEI NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Park, T. S., Zimmerlin, L., & Zambidis, E. T. (2025). Defined Xenofree Reprogramming of Cord Blood Progenitors to Induced Pluripotent and Blastomere-Like Stem Cells. Journal of Visualized Experiments. https://doi.org/10.3791/68613
Vancouver
Park TS, Zimmerlin L, Zambidis ET. Defined Xenofree Reprogramming of Cord Blood Progenitors to Induced Pluripotent and Blastomere-Like Stem Cells. Journal of Visualized Experiments. 2025. doi:10.3791/68613
BibTeX
@article{Park2025,
author = {Park, Tea Soon and Zimmerlin, Ludovic and Zambidis, Elias T},
title = {Defined Xenofree Reprogramming of Cord Blood Progenitors to Induced Pluripotent and Blastomere-Like Stem Cells},
journal = {Journal of Visualized Experiments},
year = {2025},
doi = {10.3791/68613}
}
EUVIMED